An 8‐Week Triple‐Blind, Randomized, Placebo‐Controlled Trial Evaluating High‐Dose Vitamin D3 and Flaxseed Oil for Inflammation and Metabolic Health in Elderly Patients With Type 2 Diabetes: Implications for Clinical Management
Naser Aghamohammadzadeh, Mojgan Abdi Oskoui, Neda Dolatkhah, Azizeh Farshbaf Khalili · 2026
Read An 8‐Week Triple‐Blind, Randomized, Placebo‐Controlled Trial Evaluating High‐Dose Vitamin D3 and Flaxseed Oil for Inflammation and Metabolic Health in Elderly Patients With Type 2 Diabetes: Implications for Clinical Management by Naser Aghamohammadzadeh, Mojgan Abdi Oskoui, Neda Dolatkhah, Azizeh Farshbaf Khalili (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13417724.txt.
Description
Naser Aghamohammadzadeh and colleagues run an eight week trial of vitamin D3 plus flaxseed oil in older patients with type 2 diabetes in Iran, published in 2026. The trial was triple blind and placebo controlled, enrolling 104 patients, of whom 102 finished. The active group took flaxseed oil daily and high dose vitamin D every two weeks.
The main inflammation marker fell more in the active group than in controls. Exploratory outcomes also favoured the pairing, including weight, fasting glucose, insulin resistance, triglycerides, and physical quality of life. Side effects were few. Larger trials must confirm the secondary gains before clinical adoption, the authors note.
Catalog record
| CREATOR | Naser Aghamohammadzadeh, Mojgan Abdi Oskoui, Neda Dolatkhah, Azizeh Farshbaf Khalili |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |